Clinical Trials
Permanent Manufacturer Authorization For Vetter, Rankweil
Vetter, which happens to be a global CDMO, has gone on to receive permanent manufacturer authorization as far as its clinical development site in Rankweil, Austria, is concerned.
Functional for almost a couple of years, the responsible national regulatory authority,...
Clinical Trials
Future Clinical Trials Bill To Help Regulating Trials In UK
The Policy Exchange has come up with a report that highlights the potential benefits of The Future Clinical Trials Bill when it comes to improving UK's approach in case of establishing and regulating clinical trials.
The new bill is one of...
Clinical Trials
MHRA Rolls Out New Scheme For Lowest-Risk UK Clinical Trials
The Medicines and Healthcare products Regulatory Agency has gone on to launch a new scheme that seeks to lessen the nod time when it comes to clinical trials in the UK that are at lowest risk by more than 50%.Â
The novel...
Clinical Trials
Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment
A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder (MDD).
Quotient Sciences’ Translational...
Clinical Trials
New Greenphire Study Finds Unified Technology Essential for Enhancing Patient Experience and Engagement in Clinical Trials
To better understand the ever evolving clinical trial landscape and continue to be the authority in innovation, Greenphire, the global leader in patient convenience and financial lifecycle management for clinical trials, has released its global 2023 State of Clinical Trial Patient...
Clinical Trials
BeiGene and DualityBio Announce Partnership to Advance Differentiated Antibody Drug Conjugate Therapy for Solid Tumors
BeiGene, a global biotechnology company, and DualityBio, a next-generation ADC company, announced an agreement for BeiGene to acquire an exclusive option for a global clinical and commercial license to an investigational, preclinical ADC therapy for patients with select solid...
Clinical Trials
Velocity and Privia Health Enter Partnership to Embed Clinical Research Into Practice Sites
Velocity Clinical Research, the leading multi-specialty clinical sites business, and Privia Health, a physician enablement company serving more than 3,700 providers and 4.4 million patients, today announced a partnership to open embedded clinical research sites within Privia’s practice network.
The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read